The 19q13 KRAB Zinc-finger protein ZFP82 suppresses the growth and invasion of esophageal carcinoma cells through inhibiting NF-κB transcription and inducing apoptosis.

@article{Ye2019The1K,
  title={The 19q13 KRAB Zinc-finger protein ZFP82 suppresses the growth and invasion of esophageal carcinoma cells through inhibiting NF-$\kappa$B transcription and inducing apoptosis.},
  author={Lin Ye and Tingxiu Xiang and Yu Fan and Dongsheng Zhang and Lili Li and Chong Zhang and Xiaoqian He and Qin Xiang and Q. Tao and Guosheng Ren},
  journal={Epigenomics},
  year={2019},
  volume={11 1},
  pages={
          65-80
        }
}
AIM To study the epigenetic alternations and biological functions of ZFP82 in esophageal squamous cell carcinoma. MATERIALS & METHODS Analysis of ZFP82 expression was carried out by quantitative real-time PCR. Cell function was tested by MTS cell proliferation assay, transwell assay and flow cytometry. Gene mechanisms were studied by reverse transcription-PCR (RT-PCR), quantitative real-time PCR, luciferase reporter assay and Western blot. RESULTS ZFP82 promoter methylation was… 
The tumor suppressor Zinc finger protein 471 suppresses breast cancer growth and metastasis through inhibiting AKT and Wnt/β-catenin signaling
TLDR
ZNF471 functions as a tumor suppressor that was epigenetically inactivated in breast cancer and its inhibition of AKT and Wnt/β-catenin signaling pathways is one of the mechanisms underlying its anti-cancer effects.
Methylation-regulated ZNF545 inhibits growth of the p53-mutant KYSE150 cell line by inducing p21 and Bax
TLDR
The Krüppel-associated box zinc-finger protein 545 was proposed as a potential tumor suppressor responsible for inhibiting the growth of p53-mutant ESCC cell lines and tumor-specific methylation of ZNF545 may represent an epigenetic diagnostic biomarker and a therapeutic target in patients with esophageal cancer.
The Novel Zinc Finger Protein 587B Gene, ZNF587B, Regulates Cell Proliferation and Metastasis in Ovarian Cancer Cells in vivo and in vitro
TLDR
Overexpression of ZNF587B reduced cell proliferation, colony formation, migration, and invasion, which could be reversed by knockdown of Z NF587B via siRNA, and Xenograft experiments confirmed that ZNF585B could suppress tumor growth.
Metallothionein MT1M Suppresses Carcinogenesis of Esophageal Carcinoma Cells through Inhibition of the Epithelial-Mesenchymal Transition and the SOD1/PI3K Axis
TLDR
It is demonstrated that MT1M was a novel tumor-suppressor in ESCC and may be disrupted by promoter CpG methylation during esophageal carcinogenesis.
ZNF671 Inhibits the Proliferation and Metastasis of NSCLC via the Wnt/β-Catenin Pathway
TLDR
The results confirm that the overexpression of ZNF671 inhibits cell cycle progression and metastasis of lung cancer by weakening the Wnt/β-catenin pathway, and then downregulating the expression of downstream target genes CyclinD1 and MMP9.
Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axis
TLDR
It is found that high expression of TM4SF1 is associated with lung cancer progression and appears to be required for tumor cell growth, maintenance of chemo-resistance and metastasis, and exerts these effects in part by regulating the expression of the discoidin domain receptor DDR1 and its downstream target, the Akt/ERK/mTOR pathway.
Aberrantly DNA Methylated-Differentially Expressed Genes in Pancreatic Cancer Through an Integrated Bioinformatics Approach
TLDR
The key findings of the current study demonstrate that ZNF804A, ZFP82, TRIM58, SOX17, and C12orf42 are hypermethylated/downregulated genes in pancreatic cancer and may be associated, through their modulation of specific pathways, with unfavorable Pancreatic cancer prognosis.
Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer.
TLDR
It is found that norcantharidin (NCTD) effectively induced cell senescence and cell cycle arrest in TNBC in vitro, which was accompanied by a decline in phosphorylated Akt and ERK1/2 and a rise in p21 and p16.
CMAR_A_252347 5119..5130
1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, People’s Republic of China; 2Institute of Clinical Pharmacology, Central South University, Hunan Key

References

SHOWING 1-10 OF 28 REFERENCES
Zinc-Finger Protein 545 Inhibits Cell Proliferation as a Tumor Suppressor through Inducing Apoptosis and is Disrupted by Promoter Methylation in Breast Cancer
TLDR
It is demonstrated that KRAP-ZFP protein ZNF545 inhibits breast tumor cell proliferation through inducing apoptosis and is disrupted by promoter methylation in breast cancer.
A Novel 19q13 Nucleolar Zinc Finger Protein Suppresses Tumor Cell Growth through Inhibiting Ribosome Biogenesis and Inducing Apoptosis but Is Frequently Silenced in Multiple Carcinomas
TLDR
ZNF545 was identified as a novel tumor suppressor inducing tumor cell apoptosis, repressing ribosome biogenesis and target gene transcription, and the tumor-specific methylation of ZNF545 could be an epigenetic biomarker for cancer diagnosis.
Zinc-finger protein 545 is a novel tumour suppressor that acts by inhibiting ribosomal RNA transcription in gastric cancer
TLDR
ZNF545 acts as a functional tumour suppressor in gastric cancer by inhibiting rRNA transcription and its methylation at early stages of gastric carcinogenesis is an independent prognostic factor.
Hypermethylation of ZNF545 is associated with poor prognosis in patients with early-stage hepatocellular carcinoma after thermal ablation
TLDR
The results showed reduced or loss of ZNF545 expression was found in seven human hepatic cancer cell lines, including SMMC7721, PRF/PCL-5, SK-hep1, HepG2, BEL7402, LAM3 and SNU449, by semiquantitative reverse transcription PCR.
Epigenetic identification of ZNF545 as a functional tumor suppressor in multiple myeloma via activation of p53 signaling pathway.
  • Yu Fan, Q. Zhan, +7 authors G. Ren
  • Biology, Medicine
    Biochemical and biophysical research communications
  • 2016
TLDR
ZNF545 is identified as a novel tumor suppressor inhibiting tumor growth through activation of the p53 pathway in MM and tumor-specific methylation of ZNF545 may represent an epigenetic biomarker for MM diagnosis, and a potential target for specific therapy.
Inhibition of the NF-κB transcription factor increases Bax expression in cancer cell lines
TLDR
It is demonstrated for the first time that NF-κB regulates, through an indirect pathway, the bax gene expression.
ZNF545 suppresses human hepatocellular carcinoma growth by inhibiting NF-kB signaling
TLDR
ZNF545 suppresses human HCC growth by inhibiting NF-kB signaling, and this results were validated by siRNA knocking down technique in ZNF545 highly expressed HXBF344 cells.
OPCML is frequently methylated in human colorectal cancer and its restored expression reverses EMT via downregulation of smad signaling.
TLDR
OPCML is revealed as a potential tumor suppressor gene epigenetically silenced in colon cancer and will help to elucidate the anti-invasive mechanisms of OPCML and establish new chemotherapeutic strategies for human colon cancer.
NF-kappaB-mediated induction of p21(Cip1/Waf1) by tumor necrosis factor alpha induces growth arrest and cytoprotection in normal human keratinocytes.
TLDR
It is shown that in primary cultures of human foreskin keratinocytes, TNFalpha mediates cellular growth arrest through activation of the transcription factor NF-kappaB, and the cdk inhibitor p21(Cip1/Waf1) is activated through NF- kappaB and is an important mediator of this growth arrest response.
Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas
TLDR
ROR2, as an epigenetically inactivated TSG, antagonizes both β-catenin and AKT signaling in multiple tumorigenesis, suggesting its epigenetic silencing could be a potential tumor biomarker and therapeutic target for carcinomas.
...
1
2
3
...